We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.9B
AUM Growth
+$188M
Cap. Flow
+$12.4M
Cap. Flow %
0.43%
Top 10 Hldgs %
18.86%
Holding
300
New
4
Increased
65
Reduced
71
Closed
26

Top Buys

Rank Stock Value
1
JKHY icon
Jack Henry & Associates
JKHY
+$11.4M
2
WRB icon
W.R. Berkley
WRB
+$10M
3
HEI icon
HEICO Corp
HEI
+$7.8M
4
BIIB icon
Biogen
BIIB
+$6.94M
5
ACGL icon
Arch Capital
ACGL
+$6.19M

Top Sells

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$9.07M
2
WEX icon
WEX
WEX
+$7.92M
3
BDX icon
Becton Dickinson
BDX
+$7.77M
4
HSIC icon
Henry Schein
HSIC
+$6.96M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$4.9M

Sector Composition

Rank Sector Weight
1 Technology 30.05%
2 Industrials 19.47%
3 Healthcare 16.83%
4 Consumer Discretionary 10.77%
5 Financials 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGR icon
126
Progressive
PGR
$124B
$5.52M 0.19%
76,200
FIVN icon
127
FIVE9
FIVN
$2.58B
$5.5M 0.19%
83,900
SPSC icon
128
SPS Commerce
SPSC
$2.69B
$5.46M 0.19%
98,600
BMY icon
129
Bristol-Myers Squibb
BMY
$132B
$5.46M 0.19%
85,000
-3,000
-3% -$172K
LGF.A
130
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$5.44M 0.19%
510,500
-104,500
-17% -$963K
ICUI icon
131
ICU Medical
ICUI
$4.56B
$5.41M 0.19%
28,900
VRSK icon
132
Verisk Analytics
VRSK
$23.6B
$5.38M 0.19%
36,000
SLGN icon
133
Silgan Holdings
SLGN
$4.35B
$5.36M 0.19%
172,600
CVGW
134
DELISTED
Calavo Growers
CVGW
$5.36M 0.19%
59,200
+3,400
+6% +$304K
Y
135
DELISTED
Alleghany Corp
Y
$5.36M 0.18%
6,700
EPAM icon
136
EPAM Systems
EPAM
$5.02B
$5.33M 0.18%
25,100
+1,300
+5% +$256K
UNH icon
137
UnitedHealth
UNH
$371B
$5.23M 0.18%
17,800
BIO icon
138
Bio-Rad Laboratories Class A
BIO
$9.48B
$5.03M 0.17%
13,600
BAC icon
139
Bank of America
BAC
$447B
$4.93M 0.17%
140,000
-15,000
-10% -$485K
PLAN
140
DELISTED
Anaplan, Inc.
PLAN
$4.88M 0.17%
93,200
+43,300
+87% +$2.15M
HCSG icon
141
Healthcare Services Group
HCSG
$1.5B
$4.83M 0.17%
198,800
-17,000
-8% -$421K
EXLS icon
142
EXL Service
EXLS
$5.32B
$4.71M 0.16%
339,000
+10,000
+3% +$137K
CASY icon
143
Casey's General Stores
CASY
$31.6B
$4.69M 0.16%
29,500
LULU icon
144
lululemon athletica
LULU
$14.5B
$4.63M 0.16%
20,000
JPM icon
145
JPMorgan Chase
JPM
$956B
$4.6M 0.16%
33,000
-3,000
-8% -$385K
BKNG icon
146
Booking.com
BKNG
$160B
$4.52M 0.16%
55,000
TFX icon
147
Teleflex
TFX
$5.89B
$4.52M 0.16%
12,000
+4,100
+52% +$1.41M
ZTS icon
148
Zoetis
ZTS
$30.9B
$4.5M 0.16%
34,000
-3,000
-8% -$373K
ACIA
149
DELISTED
Acacia Communications Inc
ACIA
$4.49M 0.15%
66,200
TTD icon
150
Trade Desk
TTD
$6.29B
$4.42M 0.15%
170,000

Similar funds

EULAV Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, EULAV Asset Management held 300 positions worth $2.9B, up 6.9% from $2.71B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

EULAV Asset Management's Q4 2019 filing shows 4 new, 65 increased, 71 reduced and 26 closed positions. Its largest new stake was Biogen: 25,000 shares worth $7.42M. The largest sale was Illumina, an estimated $9.07M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Industrials and Healthcare.

  • EULAV Asset Management's largest Q4 2019 buy was Biogen: 25,000 shares worth $7.42M.
  • EULAV Asset Management added most to Jack Henry & Associates in Q4 2019, an estimated $11.4M increase.
  • EULAV Asset Management's biggest Q4 2019 reduction was WEX, cutting an estimated $7.92M.
  • EULAV Asset Management fully exited Illumina in Q4 2019, selling an estimated $9.07M.
  • EULAV Asset Management's ten largest holdings make up 19% of its $2.9B portfolio in Q4 2019.
  • EULAV Asset Management opened 4 new positions and closed 26 in Q4 2019.
  • EULAV Asset Management's portfolio value rose 6.9% quarter-over-quarter to $2.9B.

Based on EULAV Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.